Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Equity Ratio (2016 - 2025)

BioCorRx's Equity Ratio history spans 16 years, with the latest figure at 1.79 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 90.4% year-over-year to 1.79; the TTM value through Sep 2025 reached 1.79, up 90.4%, while the annual FY2024 figure was 32.01, 225.09% down from the prior year.
  • Equity Ratio for Q3 2025 was 1.79 at BioCorRx, down from 1.95 in the prior quarter.
  • Across five years, Equity Ratio topped out at 25.59 in Q4 2023 and bottomed at 34.24 in Q1 2024.
  • The 5-year median for Equity Ratio is 8.49 (2021), against an average of 9.05.
  • The largest annual shift saw Equity Ratio crashed 375.24% in 2022 before it surged 339.2% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 8.49 in 2021, then dropped by 26.02% to 10.7 in 2022, then soared by 339.2% to 25.59 in 2023, then crashed by 225.09% to 32.01 in 2024, then soared by 94.41% to 1.79 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Equity Ratio are 1.79 (Q3 2025), 1.95 (Q2 2025), and 1.74 (Q1 2025).